In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Ilypsa raises $36mm with Series B venture round

Executive Summary

Biopharmaceutical company Ilypsa (formerly Symyx Therapeutics, a 2003 spin-out from Symyx Technologies) raised $36mm in a Series B round co-led by new investors US Venture Partners, Johnson & Johnson Development Corp., and Delphi Ventures. Also participating in the financing were other new investors CMEA Ventures and Mediphase Venture Partners, along with existing backers Sprout Group and 5AM Ventures.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

Advertisement
UsernamePublicRestriction

Register